The prognostic value of serum S100B in patients with cutaneous melanoma: A meta-analysis

被引:85
|
作者
Mocellin, Simone [1 ]
Zavagno, Giorgio [1 ]
Nitti, Donato [1 ]
机构
[1] Univ Padua, Dipartimento Sci Onocl & Chirurg, Clin Chirurg 2, I-35128 Padua, Italy
关键词
melanoma; S100B; serum; prognosis; meta-analysis;
D O I
10.1002/ijc.23794
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
S100B protein detected in the serum of patients with cutaneous melanoma has been long reported as a prognostic biomarker. However, no consensus exists on its implementation in the routine clinical setting. This study aimed to comprehensively and quantitatively summarize the evidence on the suitability of serum S100B to predict patients' survival. Twenty-two series enrolling 3393 patients with TNM stage I to IV cutaneous melanoma were reviewed. Standard meta-analysis methods were applied to evaluate the overall relationship between S100B serum levels and patients' survival (meta-risk). Serum S100B positivity was associated with significantly poorer survival (hazard ratio [HR] = 2.23, 95% CI: 1.92-2.58, p < 0.0001). Between-study heterogeneity was significant, which appeared to be related mainly to dissemination bias and the inclusion of patients with stage IV disease. Considering stage I to III melanoma (n = 1594), the meta-risk remained highly significant (HR = 2.28, 95% CI: 1.8-2.89; p < 0.0001) and studies' estimates were homogeneous. Subgroup analysis of series reporting multivariate survival analysis supported S100B as a prognostic factor independent of the TNM staging system. Our findings suggest that serum S100B detection has a clinically valuable independent prognostic value in patients with melanoma, with particular regard to stage I-III disease. Further investigation focusing on this subset of patients is Justified and warranted before S100B can be implemented in the routine clinical management of melanoma. (C) 2008 Wiley-Liss. Inc.
引用
收藏
页码:2370 / 2376
页数:7
相关论文
共 50 条
  • [21] Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis
    F. K. Holla
    T. J. Postma
    M. A. Blankenstein
    T. J. M. van Mierlo
    M. J. Vos
    E. M. Sizoo
    M. de Groot
    B. M. J. Uitdehaag
    J. Buter
    M. Klein
    J. C. Reijneveld
    J. J. Heimans
    Journal of Neuro-Oncology, 2016, 129 : 525 - 532
  • [22] Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis
    Holla, F. K.
    Postma, T. J.
    Blankenstein, M. A.
    van Mierlo, T. J. M.
    Vos, M. J.
    Sizoo, E. M.
    de Groot, M.
    Uitdehaag, B. M. J.
    Buter, J.
    Klein, M.
    Reijneveld, J. C.
    Heimans, J. J.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 129 (03) : 525 - 532
  • [23] Biomarker value and pitfalls of serum S100B in the follow-up of high-risk melanoma patients
    Gebhardt, Christoffer
    Lichtenberger, Ramtin
    Utikal, Jochen
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (02): : 158 - 164
  • [24] Elevated Blood S100B Levels in Patients With Migraine: A Systematic Review and Meta-Analysis
    Chu, Chaojia
    Zhong, Rui
    Cai, Mengtan
    Li, Nan
    Lin, Weihong
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [25] Clinical value of serum S100B in children with epilepsy
    Bai, Min
    Cai, Xiding
    Li, Zhen
    Huang, Lieping
    Gu, Chengping
    Li, Yanhua
    Gu, Junyang
    Han, Yiyao
    Jia, Zhai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (12): : 13535 - +
  • [26] Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients
    Gonzalez-Garcia, Sergio
    Gonzalez-Quevedo, Alina
    Fernandez-Concepcion, Otman
    Pena-Sanchez, Marisol
    Menendez-Sainz, Caridad
    Hernandez-Diaz, Zenaida
    Arteche-Prior, Marianela
    Pando-Cabrera, Alejandro
    Fernandez-Novales, Carlos
    CLINICAL BIOCHEMISTRY, 2012, 45 (16-17) : 1302 - 1307
  • [27] Prognostic factors in postoperative patients with cutaneous melanoma: a systematic review and meta-analysis
    Xia, Qi
    Ma, Qinghua
    Zhu, Jiuqun
    Gu, Lu
    Zhou, Fengling
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (05):
  • [28] Serum S100B, Lactate Dehydrogenase and Brain Metastasis Are Prognostic Factors in Patients with Distant Melanoma Metastasis and Systemic Therapy
    Weide, Benjamin
    Richter, Sabina
    Buettner, Petra
    Leiter, Ulrike
    Forschner, Andrea
    Bauer, Juergen
    Held, Laura
    Eigentler, Thomas Kurt
    Meier, Friedegund
    Garbe, Claus
    PLOS ONE, 2013, 8 (11):
  • [29] Serum S100B levels in patients with depression
    Arora, Parul
    Sagar, Rajesh
    Mehta, Manju
    Pallavi, Pooja
    Sharma, Subhadra
    Mukhopadhyay, Asok Kumar
    INDIAN JOURNAL OF PSYCHIATRY, 2019, 61 (01) : 70 - 76
  • [30] Serum S100b Levels In Patients With Depression
    Arora, Parul
    Pallavi, Pooja
    Sharma, Subhadra
    Sagar, Rajesh
    Mehta, Manju
    Mukhopadhyay, Asok K.
    INDIAN JOURNAL OF PSYCHIATRY, 2017, 59 (06) : S215 - S215